EMIS Group PLC - Trading update
Notice of half year results
Trading for the half year has been in line with the Board's expectations, despite uncertainty due to the COVID-19 crisis, albeit revenue was marginally behind the comparative period last year. Although there continues to be some uncertainty regarding the timing of new sales delivery, the Board's expectations for the full year remain unchanged.
EMIS Enterprise has grown its recurring revenues. In contrast to the comparative period in 2019, opportunities for non-recurring contracts have been limited during the lockdown period, however there are some early signs of recovery in the market.
As previously indicated, and given its strong financial position, the Group has continued to invest in the development of its strategic roadmap while carefully controlling costs across the business. It should be noted that no staff have been furloughed during the pandemic.
The Group's net cash at
Notice of half year results
The Group intends to announce its results for the half year ended
"Our NHS customers have worked tirelessly to support the nation during the COVID-19 pandemic and we thank them all for their commitment and dedication. We have been delighted to play our part in keeping mission-critical systems available throughout this period while delivering urgent solutions quickly to site.
"In particular, I am very proud of the work that the
"We have performed well as a business in adapting to these new challenges and are hopeful that our markets will continue to recover during the second half of the year.
"The Board remains confident in the outlook for the business."
For further information, contact:
Andy Thorburn, CEO
Peter Southby, CFO
Oliver Hardy/Simon Willis/James Black
MHP Communications Tel: 020 3128 8572
Reg Hoare/Giles Robinson/Florence Mayo
Information for investors, including analyst consensus forecasts, can be found on the Group's website at www.emisgroupplc.com/investors.
Notes to Editors
EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services and UK healthcare blockchain.
• Patient, the UK's leading independent provider of patient-centric medical and well-being information and related transactional services; and
• Egton, providing specialist ICT infrastructure, hardware and engineering services, and non-clinical software into health and social care.
This information is provided by RNS, the news service of the
Quick facts: EMIS Group plc
Market Cap: £674.9 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE